Ishares IBD D 2033 T EUR C ETF logo

Ishares IBD D 2033 T EUR C ETF (33GI)

Market Closed
13 Aug, 15:30
XETRA XETRA
4. 95
+0.01
+0.1336%
- Market Cap
- Div Yield
32,395 Volume
4.94
Previous Close
Add Transaction
Day Range
4.94 4.95
Year Range
4.85 5.11
Want to track 33GI and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

33GI closed Thursday higher at €4.95, an increase of 0.1336% from Wednesday's close, completing a monthly decrease of -0.9373% or -€0.05. Over the past 12 months, 33GI stock lost -1.2222%.
33GI is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on 3 different exchanges and in various currencies, with the primary listing on XETRA (EUR).

33GI Chart

Ishares IBD D 2033 T EUR C ETF (33GI) FAQ

What is the stock price today?

The current price is €4.95.

On which exchange is it traded?

Ishares IBD D 2033 T EUR C ETF is listed on XETRA.

What is its stock symbol?

The ticker symbol is 33GI.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has Ishares IBD D 2033 T EUR C ETF ever had a stock split?

No, there has never been a stock split.

Ishares IBD D 2033 T EUR C ETF Profile

XETRA Exchange
Germany Country

Overview

The iShares iBonds Dec 2033 Term Euro Corporate UCITS ETF offers a strategic investment tool designed for both institutional and retail investors looking for income generation and the benefits of bond laddering strategies. Emphasizing a structured maturity ending in December 2033, this ETF furnishes investors with a focused fixed-income investment opportunity, incorporating liquidity and cost efficiency inherent in ETF structures. It stands out in the financial market for its blend of the traditional fixed income benefits of corporate bonds with the modern efficiencies of exchange-traded funds, aiming to streamline bond investment processes for diversified portfolios.

Products and Services

  • Investment-Grade Euro-Denominated Corporate Bonds

    This product component of the ETF emphasizes offering investors exposure to a diversified pool of investment-grade corporate bonds, all denominated in euros. These bonds come from various sectors, including industrials, financial institutions, and utilities, aiming to mitigate issuer-specific risks while providing predictable income streams. The focus on investment-grade bonds seeks to balance the yield and risk, making it suitable for investors aiming for steady returns with controlled risk levels.

  • Structured Maturity ETF

    The defining characteristic of the iShares iBonds Dec 2033 Term Euro Corporate UCITS ETF lies in its predetermined maturity date in December 2033. This unique feature allows investors to plan their investment strategies with a clear time horizon, aligning the ETF’s maturity with their financial goals, such as retirement planning or saving for significant life events. The structured maturity also facilitates bond laddering strategies, where investors can manage interest rate and reinvestment risks more effectively by holding bonds that mature at different times.

  • Liquidity and Cost Efficiency

    Among the key benefits of this ETF is the combination of liquidity and cost efficiency. Unlike direct bond investments, which may require significant capital and face varying liquidity levels, the ETF format ensures investors can buy or sell shares on an exchange with ease. This liquidity, coupled with typically lower costs compared to traditional bond purchases (due to aggregating assets and trading in scale), makes the iShares iBonds Dec 2033 ETF an attractive option for investors seeking the income and safety of bonds with the added benefits typical of ETFs.

Contact Information

Address: -
Phone: -